Steven Cohen Tango Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 447,107 shares of TNGX stock, worth $3.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
447,107
Previous 447,107
-0.0%
Holding current value
$3.7 Million
Previous $3.84 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TNGX
# of Institutions
119Shares Held
89.1MCall Options Held
2.6KPut Options Held
1K-
Trv Gp Iv, LLC Boston, MA19.2MShares$159 Million81.48% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$110 Million4.04% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$67.9 Million3.91% of portfolio
-
Nextech Invest Ag5.53MShares$45.8 Million8.96% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$43.7 Million1.32% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $729M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...